Diagnosis of the follicular variant of papillary thyroid carcinoma. Interest of immunohistochemistry;Diagnostic de la variante vésiculaire du carcinome papillaire de la thyroïde. Intérêt de l'immunohistochimie

Annales de Pathologie

Volumn 23, Issue 1, 2003, Pages 11-20

  Guyétant, Serge ^a   Michalak, Sophie ^b   Valo, Isabelle ^b   Saint André, Jean Paul ^b  

^a SERVICE DE DERMATOLOGIE   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Cytokeratin 19; HBME 1; Immunohistochemistry; Papillary thyroid carcinoma; Ret

Indexed keywords

CYTOKERATIN 19; PROTEIN; PROTEIN HBME 1; PROTEIN RET; UNCLASSIFIED DRUG; DROSOPHILA PROTEIN; HBME 1 ANTIGEN; HBME-1 ANTIGEN; KERATIN; ONCOPROTEIN; PROTEIN TYROSINE KINASE; RET ONCOGENE PROTEIN, DROSOPHILA; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DYSTROPHY; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOCYTOMA; PROTEIN EXPRESSION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STAINING; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; ADENOMA; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; PAPILLARY CARCINOMA; PATHOLOGY; THYROID PARAFOLLICULAR CELL; THYROID TUMOR;

ADENOMA; ADENOMA, OXYPHILIC; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; DIAGNOSIS, DIFFERENTIAL; DROSOPHILA PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; OXYPHIL CELLS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037712550     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumors. 2nd edition. International histological classification of tumors, World Health Organisation, n° 11. Berlin: Springer-Verlag, 1988
2. Tumors of the Thyroid Gland. Atlas of Tumor Pathology, 3rd series, fasc. 5. Ed. Rosai J, Carcangiu ML, De Lellis RA. Washington DC: Armed Forces Institute of Pathology, 1992.
3. Chan JK. Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 2002; 117: 16-8.
4. Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 2002; 117: 143-50.
5. Renshaw AA, Gould EW. Why there is the tendency to « overdiagnose » the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 2002; 117: 19-21.
6. Schelfhout LJ, Van Muijen GN, Fleuren GJ. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma. Am J Clin Pathol 1989; 92: 654-8.
7. Fonseca E, Nesland JM, Hoie J, Sobrinho-Simoes M. Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins. Virchows Arch 1997; 430: 239-45.
8. Miettinen M, Kovatich AJ, Karkkainen P. Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications. Virchows Arch 1997; 431: 407-13.
9. Baloch ZW, Abraham S, Roberts S, LiVolsi VA. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. Hum Pathol 1999; 30: 1166-71.
10. Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 2001; 14: 338-42.
11. Lam KY, Lui MC, Lo CY. Cytokeratin expression profiles in thyroid carcinomas. Eur J Surg Oncol 2001; 27: 631-5.
12. Sahoo S, Hoda SA, Rosai J, DeLellis RA. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution. Am J Clin Pathol 2001; 116: 696-702.
13. Miettinen M, Karkkainen P. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours. Virchows Arch 1996; 429: 213-9.
14. Rigau V, Martel B, Evrard C, Rousselot P, Galateau-Salle F. HBME-1 immunostaining in thyroid pathology. Ann Pathol 2001; 21: 15-20.
15. Lam AK, Montone KT, Nolan KA, Livolsi VA. Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication on the histological parameters. Hum Pathol 1998; 29: 565-8.
16. Mai KT, Landry DC, Thomas J, Yazdi HM, Perkins DG, Odell PF. Ret oncogene protein expression in papillary thyroid carcinoma and related lesions. Tumori 2001; 87: 166-72.
17. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989; 63: 908-11.
18. nd ed. London: Harcourt Publishers Limited 2000. p. 959-1056.
19. McLaren KM, Cossar DW. The immunohistochemical localization of S100 in the diagnosis of papillary carcinoma of the thyroid. Hum Pathol 1996; 27: 633-6.
20. Khan A, Baker SP, Patwardhan NA, Pullman JM. CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma. Virchows Arch 1998; 432: 427-32.
21. Kilicarslan B, Pesterelli EH, Oren N, Sargin FC, Karpuzoglu G. Epithelial membrane antigen and S-100 protein expression in benign and malignant papillary thyroid neoplasms. Adv Clin Path 2000; 4: 155-8.
22. Asa SL, Cheung CC. The mind's eye. Am J Clin Pathol 2001; 116: 635-6.
23. Sheibani K, Esteban JM, Bailey A, Battifora H, Weiss LM. Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol 1992; 23: 107-16.
24. Nakamura T, Ishizaka Y, Nagao M, Hara M, Ishikawa T. Expression of the Ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J Pathol 1994; 172: 255-60.
25. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001; 357: 1644-50.
26. Coli A, Bigotti G, Zucchetti F, Negro F, Massi G. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 2002; 40: 80-7.
27. Williams ED. Guest Editorial: Two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 2000; 8: 181-3.